C 431 (Darifenacin Hydrobromide Extended-Release 7.5 mg)

Pill with imprint C 431 is White, Round and has been identified as Darifenacin Hydrobromide Extended-Release 7.5 mg. It is supplied by Cipla USA Inc.

Darifenacin is used in the treatment of overactive bladder; urinary frequency; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C 431

Darifenacin Hydrobromide Extended-Release

Imprint: C 431
Strength: 7.5 mg
Color: White
Size: 8.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Urinary antispasmodics
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Cipla USA Inc.
National Drug Code (NDC): 69097-0431
Inactive Ingredients: calcium phosphate dibasic anhydrous, hypromellose 2910 (3 mPa.s), magnesium stearate, magnesium silicate, titanium dioxide, polyethylene glycol 4000
Note: Inactive ingredients may vary.